EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier





2021
  • Pajiep M, Conte C, Huguet F, Gauthier M, Despas F, Lapeyre-Mestre M. Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France. Front Oncol. 2021 Sep 30;11:675609. doi: 10.3389/fonc.2021.675609.
  • Paternoster M, Steichen O, Lapeyre-Mestre M, Blanchon T, Rossignol L, Vilcu AM, Launay T, Sarazin M, Bagheri H, Conte C, Turbelin C, Hanslik T, Souty C. Risk of bleeding associated with nonsteroidal anti-inflammatory drug use in patients exposed to antithrombotic therapy: a case-crossover study. J Clin Pharmacol. 2021 Nov 17. doi: 10.1002/jcph.2003. Epub ahead of print.
2020
  • de Germay S, Conte C, Rascol O, Montastruc JL, Lapeyre-Mestre M. β-Adrenoceptor Drugs and Parkinson's Disease: A Nationwide Nested Case-Control Study. CNS Drugs. 2020 Jul;34(7):763-772. doi: 10.1007/s40263-020-00736-2.
     
  • Gauthier M, Conte C, Palmaro A, Patras De Campaigno E, De Barros S, Huguet F, Laurent G, Lapeyre-Mestre M, Despas F. Psychotropic drug initiation in patients diagnosed with chronic myeloid leukemia: a population-based study in France. Fundam Clin Pharmacol. 2020 Oct;34(5):612-622. doi: 10.1111/fcp.12544.
     
  • Mounié M, Costa N, Conte C, Petiot D, Fabre D, Despas F, Lapeyre-Mestre M, Laurent G, Savy N, Molinier L. Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France. J Med Econ. 2020 Mar;23(3):235-242. doi: 10.1080/13696998.2019.1702990.